The study hypotheasis is that curcumin, a natural compound with a potent antiproliferative
effect, can improve the efficacy of the standard chemotherapy gemcitabine in patients with
advanced pancreatic cancer. That is why the patients are given a daily oral dose of 8 gr of
curcumin along the chemotherapeutic protocol of weekly gemcitabine.